Clinical Trial Update: Analysis of Body Mass Index in Central Precocious Puberty Patients Treated With Leuprolide Acetate [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial analysis examines body mass index in patients with central precocious puberty treated with leuprolide acetate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Precocious Puberty

Drugs mentioned

• Leuprolide acetate (Leuprolide acetate)

Snippet

Sponsor: Kyungpook National University Hospital | Conditions: Precocious Puberty, Central | Phase 4 | Status: UNKNOWN